Founded in 2017, Redesign Science is a platform biotech working at the interface of physics-based molecular simulation and deep learning to create generative AI for drug discovery. We deploy our platform technology to develop first-in-class Protein Interaction Modulators against validated targets known to drive progression of multiple oncogenic and inflammatory diseases.
| Website | http://www.redesignscience.com |
| Employees | 5 (3 on RocketReach) |
| Founded | 2017 |
| Address | 180 Varick St, New York, New York, US |
| Technologies |
JavaScript
,
HTML
,
Twitter
+9 more
(view full list)
|
| Industry | Biotechnology Research |
| Keywords | Ai Driven Drug Discovery, Molecular Simulation, Protein Engineering, Drug Development Ai, Drug Discovery Technology, Biotechnology Software, Computational Drug Design, Pharmaceutical Ai |
| Competitors | Thermo Fisher Scientific, BD, Merck Group, Agilent Technologies, Illumina, MilliporeSigma, PerkinElmer, Inc., Bio-Rad Laboratories, QIAGEN, Invitrogen +39 more (view full list) |
Looking for a particular Redesign Science employee's phone or email?
Redesign Science Questions
3 people are employed at Redesign Science.
Redesign Science is based in New York, New York.
Top Redesign Science Employees
-
David Rooklin
Cofounder, President at Redesign Science
New York, United States24 -
Janan Zhu
Lead Infrastructure Engineer at Redesign Science
New York, NY, US22 -
Brady Garabato
Senior Scientist at Redesign Science
United States
Related Companies
G2Crowd Trusted
300K+
Plugin Users
